Earnings Per Share, Basic in USD/shares of Larimar Therapeutics, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Larimar Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2020 to Q3 2025.
  • Larimar Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.61 USD/shares, a 154% decline year-over-year.
  • Larimar Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -1 USD/shares, a 71.1% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -1.32 USD/shares, a 57.1% decline from 2023.
  • Larimar Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.84 USD/shares, a 38.7% increase from 2022.
  • Larimar Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.37 USD/shares, a 53.6% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Larimar Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 -$1 $0 -154% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$1 $0 $0 -20.6% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$1 $0 $0 -70.4% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 -$1 $0 $0 -62.1% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 -$1 $0 $0 -14.3% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$1 $0 $0 -78.9% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $0 $0 $0 -80% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $0 $0 $0 -625% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 $0 $0 +$0.16 +43.2% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 $0 $0 +$0.28 +59.6% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$1 $0 +$0.34 +69.4% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$1 $0 +$0.44 +91.7% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 -$1 $0 +$0.55 +59.8% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$2 $0 +$0.32 +40.5% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$2 $0 +$0.27 +35.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$2 $0 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 -$1 $0 -43.8% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$1 +$0.42 +34.7% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$1 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 -$1 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$1 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021

Larimar Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 $0 -57.1% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025
2023 -$1 +$0.53 +38.7% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025
2022 -$1 +$1.58 +53.6% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024
2021 -$3 +$0.62 +17.4% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 -$4 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.